BeStock  
股票 › 生物科技 › MRNA

莫德纳 MRNA

$254.19 +$12.73 (+5.27%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $256.92 +1.07%
开盘$245.40
昨收$241.46
当日区间$237.86 – $267.50
成交量16.33M
市值$101.48B
市盈率(TTM)–
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$143.00M+4.4% YoY
营业利润-$815.00M+10.1% YoY
净利润-$782.00M+5.2% YoY
摊薄每股收益-$1.97+7.5% YoY
自由现金流-$563.00M+38.9% YoY
经营现金流-$526.00M

营收,近8个季度

$1.9BSep '24$956.0MDec '24$107.0MMar '25$137.0MJun '25$1.0BSep '25$676.0MDec '25$389.0MMar '26$143.0MJun '26

净利润,近8个季度

$13.0MSep '24$-1.1BDec '24$-971.0MMar '25$-825.0MJun '25$-200.0MSep '25$-826.0MDec '25$-1.3BMar '26$-782.0MJun '26

各季度摊薄每股收益

0.03Sep '24-2.91Dec '24-2.52Mar '25-2.13Jun '25-0.51Sep '25-2.11Dec '25-3.40Mar '26-1.97Jun '26

各季度自由现金流

$-1.7BSep '24$303.0MDec '24$-1.2BMar '25$-922.0MJun '25$-880.0MSep '25$891.0MDec '25$-692.0MMar '26$-563.0MJun '26

年度营收

$274.0MFY20$17.7BFY21$18.9BFY22$6.8BFY23$3.2BFY24$1.9BFY25

盈利能力与资产负债表

毛利率22.8%
营业利润率-150.2%
净利率-142.6%
净资产收益率-39.0%
资产收益率-27.4%
投入资本回报率-36.2%
流动比率2.29
负债/资产比率38.3%
现金及投资$5.14B
总负债$1.24B
净现金(净负债)$3.90B

营收构成

2026/Q2 季度

按业务线

  • COVID$91.00M 62.8%
  • Other revenue$51.00M 35.2%
  • Respiratory syncytial virus (RSV)$3.00M 2.1%

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $145.00M $389.00M $1.94B $678.00M $1.02B
营业总收入 $143.00M $389.00M $1.92B $676.00M $1.00B
营业成本 $93.00M $955.00M $868.00M $452.00M $207.00M
毛利润 $50.00M -$566.00M $1.05B $224.00M $795.00M
营业费用 $865.00M $822.00M $4.13B $1.08B $1.06B
销售及管理费用 $216.00M $173.00M $1.02B $308.00M $268.00M
研发费用 $651.00M $649.00M $3.13B $775.00M $801.00M
其他营业费用 -$2.00M – -$22.00M -$2.00M -$14.00M
营业利润 -$815.00M -$1.39B -$3.07B -$857.00M -$260.00M
非经营性利息净收入(支出) $50.00M $55.00M $304.00M $62.00M $73.00M
非经营性利息收入 $67.00M $72.00M $314.00M $70.00M $73.00M
非经营性利息支出 $17.00M $17.00M $10.00M $8.00M $0.00
其他收入(支出) -$2.00M -$1.00M $2.00M -$4.00M –
其他非经营性收入(支出) -$2.00M – $7.00M -$2.00M -$4.00M
税前利润 -$767.00M -$1.33B -$2.77B -$799.00M -$187.00M
税费 $15.00M $9.00M $54.00M $27.00M $13.00M
净利润 -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
持续经营利润 -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
归属母公司净利润 -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
归属普通股股东净利润 -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
基本每股收益 -$1.97 -$3.40 -$7.26 -$2.11 -$0.51
摊薄每股收益 -$1.97 -$3.40 -$7.26 -$2.11 -$0.51
证券出售收益 – -$1.00M -$5.00M -$2.00M $4.00M

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $10.96B $11.49B $12.34B $12.34B $12.14B
流动资产合计 $5.82B $5.77B $6.54B $6.54B $6.60B
现金及现金等价物与短期投资 $5.14B $5.21B $5.80B $5.80B $4.50B
-现金及现金等价物 $1.72B $1.91B $2.60B $2.60B $1.13B
-短期投资 $3.42B $3.30B $3.20B $3.20B $3.37B
应收款 $139.00M $182.00M $284.00M $284.00M $1.39B
-应收账款 $17.00M $71.00M $184.00M $184.00M $1.05B
-应计应收利息 $40.00M $39.00M $42.00M $42.00M $40.00M
-应收税款 $51.00M $64.00M $45.00M $45.00M $104.00M
-其他应收款 $31.00M $8.00M $13.00M $13.00M $204.00M
预付资产 $216.00M $186.00M $263.00M $263.00M $312.00M
存货 $280.00M $146.00M $153.00M $153.00M $332.00M
其他流动资产 $42.00M $51.00M $45.00M $45.00M $56.00M
非流动资产合计 $5.15B $5.72B $5.79B $5.79B $5.54B
固定资产净值 $2.76B $2.79B $2.85B $2.85B $2.86B
-固定资产原值 $3.61B $3.59B $3.59B $3.59B $3.54B
-累计折旧 -$849.00M -$794.00M -$737.00M -$737.00M -$671.00M
投资及预付款 $1.77B $2.25B $2.34B $2.34B $2.15B
-可供出售证券 $1.77B $2.25B $2.34B $2.34B $2.14B
一年以上应收账款 $161.00M $161.00M $161.00M $161.00M $99.00M
一年以上预付资产 $90.00M $97.00M $100.00M $100.00M $105.00M
商誉及其他无形资产 $161.00M $168.00M $97.00M $97.00M $99.00M
-商誉 $52.00M $52.00M $52.00M $52.00M $52.00M
-其他无形资产 $109.00M $116.00M $45.00M $45.00M $47.00M
一年以上递延资产 $82.00M $82.00M $81.00M $81.00M $81.00M
其他非流动资产 $124.00M $167.00M $160.00M $160.00M $137.00M
负债合计 $4.20B $4.08B $3.69B $3.69B $2.81B
流动负债合计 $2.53B $2.40B $1.99B $1.99B $1.68B
应付款 $167.00M $161.00M $317.00M $317.00M $267.00M
-应付账款 $167.00M $161.00M $317.00M $317.00M $267.00M
一年内应计费用 $1.30B $1.33B $457.00M $457.00M $442.00M
短期债务及融资租赁负债 $52.00M $50.00M $42.00M $42.00M $48.00M
-一年内到期融资租赁负债 $52.00M $50.00M $42.00M $42.00M $48.00M
一年内预提费用 $421.00M $470.00M $509.00M $509.00M $426.00M
一年内递延负债 $295.00M $102.00M $99.00M $99.00M $163.00M
其他流动负债 $111.00M $170.00M $143.00M $143.00M $25.00M
非流动负债合计 $1.67B $1.69B $1.70B $1.70B $1.12B
长期应付账款及其他应付款 $255.00M $253.00M $249.00M $249.00M $239.00M
长期债务及融资租赁负债 $1.24B $1.25B $1.26B $1.26B $686.00M
-长期债务 $591.00M $590.00M $590.00M $590.00M –
-长期融资租赁负债 $644.00M $658.00M $673.00M $673.00M $686.00M
一年以上递延负债 $147.00M $154.00M $153.00M $153.00M $157.00M
其他非流动负债 $29.00M $30.00M $36.00M $36.00M $42.00M
股东权益合计 $6.76B $7.41B $8.65B $8.65B $9.33B
股东权益 $6.76B $7.41B $8.65B $8.65B $9.33B
股本 $0.00 $0.00 $0.00 $0.00 $0.00
-普通股 $0.00 $0.00 $0.00 $0.00 $0.00
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
资本公积 $1.64B $1.50B $1.38B $1.38B $1.25B
留存收益 $5.10B $5.88B $7.22B $7.22B $8.05B
不影响留存收益的损益 $19.00M $25.00M $45.00M $45.00M $27.00M
-长期股权投资 – – $6.00M $6.00M $9.00M

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 -$526.00M -$630.00M -$1.87B $930.00M -$847.00M
持续经营经营活动现金流净额 -$526.00M -$630.00M -$1.87B $930.00M -$847.00M
持续经营净利润 -$782.00M -$1.34B -$2.82B -$826.00M -$200.00M
持续经营损益 $0.00 $2.00M $8.00M $3.00M -$3.00M
折旧、折耗与摊销 $63.00M $59.00M $215.00M $67.00M $52.00M
其他非现金项目 $4.00M $6.00M $77.00M $27.00M $14.00M
营运资金变动 $79.00M $553.00M $233.00M $1.56B -$818.00M
-应收款变动 $53.00M $114.00M $156.00M $859.00M -$1.01B
-存货变动 -$132.00M $6.00M -$34.00M $179.00M -$91.00M
-预付资产变动 $16.00M $54.00M $153.00M $237.00M $66.00M
-应付账款及应计费用变动 $3.00M $344.00M -$94.00M $216.00M $288.00M
-其他流动资产变动 $10.00M $11.00M $38.00M $10.00M $9.00M
-其他流动负债变动 -$61.00M $19.00M -$27.00M $125.00M -$117.00M
-其他营运资金变动 $190.00M $5.00M $41.00M -$67.00M $40.00M
投资活动现金流净额 $329.00M -$76.00M $1.95B -$48.00M $700.00M
持续经营投资活动现金流净额 $329.00M -$76.00M $1.95B -$48.00M $700.00M
固定资产购置及出售净额 -$37.00M -$62.00M -$192.00M -$39.00M -$33.00M
无形资产购置及出售净额 $0.00 $0.00 -$10.00M $0.00 $0.00
投资购置及出售净额 $366.00M -$14.00M $2.15B -$9.00M $733.00M
筹资活动现金流 $14.00M $17.00M $593.00M $581.00M -$1.00M
持续经营筹资活动现金流净额 $14.00M $17.00M $593.00M $581.00M -$1.00M
债务发行及偿还净额 -$7.00M $0.00 $560.00M $566.00M -$3.00M
普通股发行净额 $23.00M $19.00M $35.00M $16.00M $2.00M
其他筹资费用净额 -$2.00M -$2.00M -$2.00M -$1.00M $0.00
期末现金余额 $1.72B $1.91B $2.60B $2.60B $1.13B
现金净变动 -$183.00M -$689.00M $666.00M $1.46B -$148.00M
期初现金余额 $1.91B $2.60B $1.93B $1.13B $1.28B
汇率变动影响 -$2.00M $1.00M $2.00M $0.00 $1.00M
自由现金流 -$563.00M -$692.00M -$2.08B $891.00M -$880.00M
业务购买及出售净额 – – $0.00 – –

讨论区

暂无评论——快来第一个聊聊 MRNA。

登录后参与讨论。

Scroll to Top